M 6 A Modification | List of Frontiers open access articles

Review

Published on 16 Jul 2024

Detection, distribution, and functions of RNA N6-methyladenosine (m6A) in plant development and environmental signal responses

in Plant Physiology

Yang Xiang
Dian Zhang
Lei Li
Yi-Xuan Xue
Chao-Yang Zhang
Qing-Feng Meng
Jin Wang
Xiao-Li Tan
Yu-Long Li

Frontiers in Plant Science

doi 10.3389/fpls.2024.1429011

5,107 views
11 citations

Review

Published on 14 Jul 2023

CRISPR-based m6A modification and its potential applications in telomerase regulation

in Epigenomics and Epigenetics

Mingliang Yi
Mingyue Wang
Yongjie Xu
Zhikun Cao
Yinghui Ling
Zijun Zhang
Hongguo Cao

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1200734

7,233 views
4 citations

Review

Published on 30 Sep 2024

Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery

in Anti-Cancer Drugs

Honghai Zhang
Xueer Wang
Jianjun Chen
Rui Su

Frontiers in Drug Discovery

doi 10.3389/fddsv.2024.1465222

3,494 views
4 citations

Review

Published on 04 Sep 2024

Regulatory effect of N6-methyladenosine on tumor angiogenesis

in Cancer Immunity and Immunotherapy

YuYan
Enwu Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1453774

3,202 views
3 citations

Original Research

Published on 20 Mar 2024

Characterization of the m6A regulators’ landscape highlights the clinical significance of acute myocardial infarction

in Inflammation

Peng Chao
Xueqin Zhang
Lei Zhang
Yong Wang
Miriban Wusiman
Gulizere Aimaijiang
Xiaoyang Chen
Yining Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1308978

3,355 views
5 citations

Original Research

Published on 25 Jul 2024

A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Shaohua Xu
Yi Zhang
Ying Yang
Kexin Dong
Hanfei Zhang
Chunhua Luo
Song-Mei Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374465

4,330 views
3 citations

Original Research

Published on 30 Aug 2024

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL

in Pharmacology of Anti-Cancer Drugs

Yuxin Hong
Hehua Ma
Haoyi Yang
Yuning Zhu
Yuan Wei
Zhenzhen Xu
Yuwen Zhang
Dandan Jin
Zhiyou Chen
Wei Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447830

3,588 views
1 citation

Review

Published on 15 Dec 2023

m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy

in Cancer Immunity and Immunotherapy

Chen Peng
Fen Xiong
Xi Pu
Zhangmin Hu
Yufei Yang
Xuehan Qiao
Yuchun Jiang
Miao Han
Deqiang Wang
Xiaoqin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1326031

4,861 views
12 citations

Review

Published on 06 Dec 2023

New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification

in RNA

Songtao Liu
Dayong Xiang

Frontiers in Genetics

doi 10.3389/fgene.2023.1270983

4,094 views
8 citations

Original Research

Published on 25 Aug 2023

The m6A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Ensi Ma
Jianhua Li
Conghuan Shen
Yange Gu
Xinju Zhang
Li Li
Jing Zhao
Zhengxin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1227593

4,713 views
3 citations

Articles

Detection, distribution, and functions of RNA N6-methyladenosine (m6A) in plant development and environmental signal responses

CRISPR-based m6A modification and its potential applications in telomerase regulation

Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery

Regulatory effect of N6-methyladenosine on tumor angiogenesis

Characterization of the m6A regulators’ landscape highlights the clinical significance of acute myocardial infarction

A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL

m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy

New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification

The m6A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma